Federación de Rusia #4256 (v.1)
Datos básicos
- Notificada en
-
G/MA/QR/N/RUS/1 14/09/2012
- Validez de la versión
-
01/10/2012 -
01/10/2014
Versión anterior v.1
- Miembro informante
- Federación de Rusia
- En vigor desde
- Fecha de supresión
- En vigor
- Descripción general
-
Import licensing for import of medicines and pharmaceutical products
- Fundamento jurídico nacional
-
"Common List of Goods that are subject of import/export prohibitions or restrictions from the part of CU members within the framework of Eurasian Economic Community in trade with third countries and Regulations about restrictions application." (came into force 1 january 2010) adopted by EurAsEC Board of Heads of States Decision № 19 of 27 November 2009 and introduced by CU Commission Decision № 132 of 27 November 2009 "On a Single Non-Tariff Regulation of the Customs Union of the Republic of Belarus, Republic of Kazakhstan and the Russian Federation" (as last amended on 26 July 2012)
- Mecanismo administrativo
-
Conclusion (permition) of the authorized body is not required at the placement under the following customs procedures: production for domestic consumption, processing for domestic consumption, reimport or abandonment to the State of unregistered medicines for clinical researches, medicines examinations,state registration of medicines, delivery of healf care according to vital indicators of individual patient or delivery of healf care to a limited contingent of patients with rare and (or) a particularly severe pathology, and of registered medicines intended for clinical researches, as well as registered or unregistered medicines intended for humanitarian aid (assistance), aid in emergency situations
- Entidades responsables
-
- Versión del SA
-
HS 2012
- Signatura de la OMC a que se hace referencia
-
Metadatos
- Justificaciones en el marco de la OMC
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Notificada como: Article XX(b) GATT - Compromisos Internacionales (distintos de los asumidos en el marco de la OMC)
-
- Interlocutores afectados
- Interlocutores no afectados
Medidas
- Restricciones notificadas
- NAL
Signatura |
---|
NAL
|
Líneas arancelarias
210690
|
Ex 2106 90 980 3
Ex 2106 90 980 9 |
Prepaprations containing vitamins and mineral substances, used for medical purposes
Prepaprations... |
|
2904
|
Ex 2904
|
Organic chemical compounds used as pharmaceutical substances
|
|
2905
|
Ex 2905
|
Organic chemical compounds used as pharmaceutical substances Interpreted as from to "2904 - ex 29...
|
|
2906
|
Ex 2906
|
Organic chemical compounds used as pharmaceutical substances Interpreted as from to "2904 - ex 29...
|
|
2907
|
Ex 2907
|
Organic chemical compounds used as pharmaceutical substances Interpreted as from to "2904 - ex 29...
|
|
2908
|
Ex 2908
|
Organic chemical compounds used as pharmaceutical substances Interpreted as from to "2904 - ex 29...
|
|
2909
|
Ex 2909
|
Organic chemical compounds used as pharmaceutical substances Interpreted as from to "2904 - ex 29...
|
|
2912
|
Ex 2912
|
Organic chemical compounds used as pharmaceutical substances
|
|
2913
|
Ex 2913
|
Organic chemical compounds used as pharmaceutical substances
|
|
2914
|
Ex 2914
|
Organic chemical compounds used as pharmaceutical substances
|
|
2915
|
Ex 2915
|
Organic chemical compounds used as pharmaceutical substances
|
|
2916
|
Ex 2916
|
Organic chemical compounds used as pharmaceutical substances
|
|
2917
|
Ex 2917
|
Organic chemical compounds used as pharmaceutical substances
|
|
2918
|
Ex 2918
|
Organic chemical compounds used as pharmaceutical substances
|
|
2919
|
Ex 2919
|
Organic chemical compounds used as pharmaceutical substances
|
|
2920
|
Ex 2920
|
Organic chemical compounds used as pharmaceutical substances
|
|
2921
|
Ex 2921
|
Organic chemical compounds used as pharmaceutical substances
|
|
2922
|
Ex 2922
|
Organic chemical compounds used as pharmaceutical substances
|
|
2923
|
Ex 2923
|
Organic chemical compounds used as pharmaceutical substances
|
|
2924
|
Ex 2924
|
Organic chemical compounds used as pharmaceutical substances
|
|